Published in Science · View the paper (DOI)
Researchers at MIT and Scripps Research Institute have developed a vaccine that generates a significant population of rare precursor B cells capable of evolving to produce broadly neutralizing antibodies against HIV. The DNA-VLP approach shows potential for inducing broadly neutralizing antibody responses against influenza as well.
Coverage from 2 institutions